United States health panel for the first time support the use of HIV prevention drug to healthy people.
Panel recommends United States regulators to approve a daily pill, Truvada, to be used by healthy people who are considered at high risk of the virus that causes AIDS. Previously a number of health workers and community groups are active in refusing HIV drugs. The rejection was based on the consideration that the user will get a false sense of security and fears of the emergence of a new type of HIV drug resistance.
On the other hand, those who support the Truvada reasoned that the use of the drug solely for HIV prevention efforts. That effort was not to be used as a single effort of prevention, because other efforts continue to run as a safe sex campaign, use of protective equipment, and routine testing.
Truvada long as it’s used for people with HIV and drug use in conjunction with anti-retroviral drugs. Results of the study in 2010 showed that Truvada, a drug made ? by Gilead Sciences, based in California, can reduce HIV risk in healthy homosexual men and also for HIV among heterosexual HIV-negative but have positive partners, between 44 percent to 73 percent.
Food and drug watchdog United States. FDA panel will consider the proposal and is expected to make a final decision on 15 June.
- SAP HIV AIDS